Attention-deficit/hyperactivity disorder

  title={Attention-deficit/hyperactivity disorder},
  author={Stephen V. Faraone and Philip J Asherson and Tobias Banaschewski and Joseph Biederman and Jan K. Buitelaar and Josep Antoni Ramos-Quiroga and Luis Augusto Rohde and Edmund J. S. Sonuga-Barke and Rosemary Tannock and Barbara Franke},
  journal={Nature Reviews Disease Primers},
Attention-deficit/hyperactivity disorder (ADHD) is a persistent neurodevelopmental disorder that affects 5% of children and adolescents and 2.5% of adults worldwide. Throughout an individual's lifetime, ADHD can increase the risk of other psychiatric disorders, educational and occupational failure, accidents, criminality, social disability and addictions. No single risk factor is necessary or sufficient to cause ADHD. In most cases ADHD arises from several genetic and environmental risk factors… 

ADHD across the lifespan

New findings on attention/hyperactivity disorder: what is (not) known?

Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder which is characterized by inattention, hyperactivity and/or impulsivity. It affects roughly one out of twenty children

Attention deficit hyperactivity disorder.

Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype/Presentation: Research Progress and Translational Studies

The Research Domain Criteria has been proposed to provide a novel framework for understanding the nature of neuropsychiatric illnesses and ultimately improve their diagnosis and treatment.

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

It is confirmed that persistent ADHD in adults is a neurodevelopmental disorder and the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective is extended.

Insomnia Disorder in Adult Attention-Deficit/Hyperactivity Disorder Patients: Clinical, Comorbidity, and Treatment Correlates

Insomnia disorder is highly prevalent in adult ADHD and is related to higher ADHD severity and more psychiatric and medical comorbidities and stable pharmacological ADHD treatment are associated with better outcomes.

Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review

Adjunctive cognitive-behavior therapy for anxiety disorder symptoms is strongly recommended and is considered superior to medication alone, and in moderate and severe cases of comorbid Ads, selective serotonin reuptake inhibitors can be added to the stimulants, with the required caution.

Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review

Background The development of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs) has various influences on physical abilities. Identification of specific physical

Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study

Adult ADHD remained associated with all comorbidities in older adults aged 50 to 64 when all conditions were assessed from age 50 onwards and Clinicians should remain vigilant for a wide range of psychiatric and metabolic problems in ADHD affected adults of all ages and both sexes.



ADHD: Prevalence, Diagnosis, and Issues of Comorbidity

  • T. Wilens
  • Psychology, Medicine
    CNS Spectrums
  • 2007
Acute and long-term use of long-acting stimulant formulations (methylphenidate and amphetamine compounds) have shown robust efficacy and tolerability consistent with the treatment response established in children with ADHD, and non-stimulant medications have demonstrated efficacy as well, and may be preferred in patients with tic and substance use disorders.

Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?

It is suggested that adults with ADHD and a high IQ display patterns of functional impairments, familiality and psychiatric co-morbidities that parallel those found in the average-IQ adult ADHD population.

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

  • L. AdlerJ. Cohen
  • Psychology, Medicine
    The Psychiatric clinics of North America
  • 2004

[Attention deficit hyperactivity disorder in adults. An overview].

Current results of epidemiology, etiology, clinical symptoms and comorbidity, diagnostic assessment, pharmacotherapy, and psychological interventions for adults with ADHD are discussed.

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

The results show that referred and nonreferred adults with attention deficit hyperactivity disorder have a pattern of demographic, psychosocial, psychiatric, and cognitive features that mirrors well-documented findings among children with the disorder.

Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors.

The findings suggest the existence of 2 familial pathways to cognitive impairments in ADHD and indicate promising cognitive targets for future molecular genetic investigations.

Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder

The finding that ADHD + CP can represent a familial distinct subtype possibly with a distinct genetic etiology is consistent with a high risk for cosegregation and provides partial support for the ICD-10 distinction betweenhyperkinetic disorder and hyperkinetic conduct disorder.

Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.

These opportunities to explain attention-deficit/hyperactivity disorder (ADHD)-related risk of substance use disorder (SUD) remain available for study by considering characteristics of children with ADHD and factors affecting their outcomes side by side with overlapping variables in the developmental literature on SUD etiology.

Medication for attention deficit-hyperactivity disorder and criminality.

It is raised the possibility that the use of medication reduces the risk of criminality among patients with ADHD, and rates of criminality were lower during periods when they were receiving ADHD medication.